Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus

[1]  H. Roschel,et al.  Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance , 2018, Arthritis care & research.

[2]  B. Rovin,et al.  Update on Lupus Nephritis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[3]  L. See,et al.  Risk of end‐stage renal disease in systemic lupus erythematosus patients: a nationwide population‐based study , 2016, International journal of rheumatic diseases.

[4]  M. Ward,et al.  Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis , 2016, Arthritis & rheumatology.

[5]  M. Halim,et al.  Diabetic kidney disease: world wide difference of prevalence and risk factors , 2015, Journal of nephropharmacology.

[6]  M. Said,et al.  Steroid‐induced diabetes mellitus in systemic lupus erythematosus patients: analysis from a Malaysian multi‐ethnic lupus cohort , 2015, International journal of rheumatic diseases.

[7]  R. Weiss,et al.  Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment , 2014, Diabetes/metabolism research and reviews.

[8]  Chao-Yu Guo,et al.  Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all‐cause mortality: a nationwide cohort study in Taiwan , 2013, International journal of rheumatic diseases.

[9]  M. Segal,et al.  Lupus Nephritis and End-stage Kidney Disease , 2013, The American journal of the medical sciences.

[10]  B. Parker,et al.  SLE and metabolic syndrome , 2013, Lupus.

[11]  M. Yeganeh,et al.  Risk Factors of Glucocorticoid-Induced Diabetes Mellitus in Systemic Lupus Erythematosus , 2013, Galen Medical Journal.

[12]  Chih-Chiang Chien,et al.  Epidemiology and Mortality of New-Onset Diabetes After Dialysis , 2013, Diabetes Care.

[13]  A. Major,et al.  Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus. , 2012, American journal of physiology. Endocrinology and metabolism.

[14]  C. Yen,et al.  Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  L. Geiss,et al.  Incidence of Treatment for End-Stage Renal Disease Among Individuals With Diabetes in the U.S. Continues to Decline , 2010, Diabetes Care.

[16]  T. Tso,et al.  Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus , 2009, Rheumatology International.

[17]  D. Isenberg,et al.  Diabetes mellitus complicating systemic lupus erythematosus – analysis of the UCL lupus cohort and review of the literature , 2008, Lupus.

[18]  M. Abrahamowicz,et al.  Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? , 2008, Arthritis and rheumatism.

[19]  D. Isenberg,et al.  Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality , 2007, Annals of the Rheumatic Diseases.

[20]  Gerald McGwin,et al.  Time to Renal Disease and End-Stage Renal Disease in PROFILE: A Multiethnic Lupus Cohort , 2006, PLoS medicine.

[21]  I. Bruce.  'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. , 2005, Rheumatology.

[22]  I. Bruce,et al.  Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. , 2003, Arthritis and rheumatism.

[23]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[24]  R. Pauzner,et al.  Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus , 2001, Lupus.

[25]  A. H. Smith,et al.  THE AMERICAN JOURNAL OF THE MEDICAL SCIENCES , 1898 .

[26]  S. De Cosmo,et al.  Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  I. Bruce,et al.  Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. , 2006, Journal of Rheumatology.